A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
about
Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysisHepatitis C treatment: current and future perspectivesExtent of liver inflammation in predicting response to interferon α & Ribavirin in chronic hepatitis C patients: a cohort study.The role of interleukin-28b gene polymorphisms in chinese patients with chronic hepatitis C treated with pegylated interferon and ribavirin.Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients.Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy.Molecular epidemiologic characterization of a clustering HCV infection caused by inappropriate medical care in Heyuan City of Guangdong, China.Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan.Chronic hepatitis C virus infection and increases in viral load in a prospective cohort of young, HIV-uninfected injection drug usersHepatitis C virus infection: molecular pathways to insulin resistance."Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china.Real response to therapy in chronic hepatitis C virus patients: a study from iran.Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?A comparison of modified directly observed therapy to standard care for chronic hepatitis C.A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges.Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.Comparison of structural architecture of HCV NS3 genotype 1 versus Pakistani genotype 3a.The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.End treatment response and sustained viral response in hepatitis C virus genotype 3 among Pakistani population.Sustained virological response rates to antiviral therapy in genotype 1 and 3 chronic hepatitis C patients: a study from north India.Presence of HCV RNA in peripheral blood mononuclear cells may predict patients response to interferon and ribavirin therapy.The genotype CC of IL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients.Genetic variant of IL28B rs12979860, as predictive marker of interferon-based therapy in Pakistani population.Emergence of genetically variant Hepatitis C virus population in response to increased antiviral drug pressure, Pakistan.Identification of rare hepatitis C virus genotype 5a among Indian population.Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcome.Estimating the likelihood of sustained virological response in chronic hepatitis C therapy.Association between human leucocyte antigen-DO polymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study.
P2860
Q26991791-41CAAA23-794D-42D4-B20A-B59085147467Q34147323-ED2077F5-0A3A-4256-9B9C-8D0D394CABE2Q34304221-16B5C1A8-E9C9-4AE3-B61D-3AE1461914D2Q34348799-F9236FA1-ECD6-4AB5-9550-746455261280Q35040102-44AC4D6A-4D47-4751-9E41-1DC28F6D4A2AQ35053127-A4CA9636-7F99-4717-8CA9-90A1F4439C97Q35070175-A5A31E54-F329-4D25-9732-922180638BCEQ35153914-449EA21B-10FE-452A-9F68-4A2A72741A5AQ35501675-399DE33B-6585-4BE6-BE8E-84E722F4454CQ35505394-66AD4A64-E75C-4CE5-93C5-59D06AD39132Q35575885-93678618-2C6C-4EE0-B9B0-B369BE0C88C0Q35920144-615538FC-D946-4EF6-8FB3-389E80096FEEQ36329140-EE95066A-A10B-4EFB-A8C0-F251487325F3Q36418455-677FBA50-970F-472D-9F0B-0C945FC55825Q36997166-88367161-6741-42ED-ACB2-4C0B23EAA596Q37608313-BD844392-6F6A-4326-8EB6-123408042D80Q38853078-647735B8-88AE-41B8-A6DC-82B9251883DDQ39097394-043D17E3-E593-48D0-AFD7-6AADCD615F50Q39112435-047EA7D2-1F0B-43AE-8B4C-FDA2EDF29322Q39199679-2C4584D0-E5BD-4AC0-BB90-E041B71443A2Q41257949-C27D3D1E-151C-4512-8221-A3B6B9789FE1Q41366464-FB9B2A30-773E-4BA9-9614-F3EF9B065165Q41467901-92566F29-0B7F-4E1F-B306-2F3B1FEB4D13Q41471133-27E0420D-E398-4DDB-910A-F27CF09D4C70Q42236748-BBFE887E-5DD0-4B84-A0AB-DA145D80A263Q42991094-72052BC0-B389-4F98-956C-136C5E4775A2Q48286494-11FF3713-2E1D-4F86-BF23-AE8180BAEB86Q50558649-001E6973-EDCF-4FF5-AEE2-C56BBC9827F8Q52589250-B6453D1E-B28C-4E72-A519-D38D66A5D8C0
P2860
A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A study of best positive predi ...... e chronic hepatitis C patients
@ast
A study of best positive predi ...... e chronic hepatitis C patients
@en
A study of best positive predi ...... e chronic hepatitis C patients
@nl
type
label
A study of best positive predi ...... e chronic hepatitis C patients
@ast
A study of best positive predi ...... e chronic hepatitis C patients
@en
A study of best positive predi ...... e chronic hepatitis C patients
@nl
prefLabel
A study of best positive predi ...... e chronic hepatitis C patients
@ast
A study of best positive predi ...... e chronic hepatitis C patients
@en
A study of best positive predi ...... e chronic hepatitis C patients
@nl
P2860
P356
P1433
P1476
A study of best positive predi ...... e chronic hepatitis C patients
@en
P2093
Sheikh Riazuddin
P2860
P2888
P356
10.1186/1471-230X-9-5
P577
2009-01-20T00:00:00Z
P6179
1024240108